 |
|
|
| |
Rapid HBsAg Reduction in Chronic Hepatitis B Virus Infection: Preliminary Results From a Phase 1 Study Evaluating a Single Dose of VIR-3434, a Novel Neutralizing, Vaccinal Monoclonal Antibody
|
| |
| |
AASLD 2021 Nov 12-15
Kosh Agarwal,1 Man-Fung Yuen,2 Heiner Wedemeyer,3 Andre Arizpe,4 Ling Shen,4 Daniel Cloutier,4 Chin Tay,4 Sneha V. Gupta,4 Marie Fanget,4 Sanjay L. Dholakiya,4 Lillian Seu,4 Andrea L. Cathcart,4 Carey Hwang,4 Phillip S. Pang,4 and Edward Gane5
1Institute of Liver Studies, Kings College Hospital, London, United Kingdom; 2Queen Mary Hospital, University of Hong Kong, Hong Kong, China; 3Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 4Vir Biotechnology Inc., San Francisco, California, United States; 5University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
